Pacific Biosciences: Boom In Genome Sequencing Technology With 35% Upside Aug. 04, 2021 7:30 AM ET Pacific Biosciences of California, Inc. (PACB) Stock PACB 8 Comments 4 Likes Khaveen Investments ...

Illumina, the dominant maker of DNA sequencing machines, has agreed to purchase smaller rival Pacific Biosciences for $8 a share, or $1.2 billion, in an effort to cement its ownership of cutting ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, has been gaining from its continued product ...

Pacific Biosciences of California, Inc. PACB recently introduced the Sequel IIe System, the next instrument evolution powered by its Single Molecule, Real-Time (SMRT) Sequencing technology.This ...

Pacific Biosciences of California (NASDAQ:PACB) specializes in genetic sequencing technology. The company is well-known for its Single Molecule, Real-Time [SMRT] sequencing technology, which ...

MENLO PARK, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced a ...

MENLO PARK, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes ...

Pacific Biosciences of California, Inc., a pioneer and leader in long-read sequencing using its Single Molecule, Real-Time (SMRT®) Technology, today announced it has launched a new nucleic acid ...

Pacific Biosciences CTO Stephen Turner says that the company can complete that mission within the next five years. With it, a "raw" human sequence could be done in three minutes, reports Bio-IT World.

Pacific Biosciences, a Menlo Park, Calif., firm best known for its niche approach to DNA sequencing, on Tuesday announced plans to launch a new product that will put the company in direct ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently partnered with Rady Children’s Institute for Genomic Medicine (“RCIGM”) for a research related to whole ...

Pacific Biosciences has gained $100 million in venture funds to accelerate its work on new technology that will permit gene sequencing virtually on demand. And the company's CEO is telling investors ...